GAITHERSBURG, MD, August 7, 2012 Sigma-Tau Pharmaceuticals, Inc., is excited to introduce a new probiotic medical food for children with IBS. A study published in the Journal of Pediatric Gastroenterology and Nutrition (1) , found that VSL#3, a high-potency probiotic medical food, provided a beneficial role in the dietary management of children who suffer from irritable bowel syndrome (IBS), a common problem for which there is no cure. This finding led Sigma-Tau, distributor of VSL#3, to develop and introduce new VSL#3 JUNIOR; a high-potency probiotic medical food for the dietary management of irritable bowel syndrome (IBS) and ulcerative colitis (UC) in children. New VSL#3 JUNIOR is now available through participating pharmacies behind the counter.
"One of the most obscure consequences of IBS in children is the way these conditions affect their entire family," expresses Mary Ocnean, senior product manager at Sigma-Tau Pharmaceuticals. "VSL#3 has been clinically proven to provide significant improvement in family life disruption scores and in reducing the discomfort and bloating of IBS. It is the first probiotic medical food that has been studied in a pediatric, randomized, double-blind, placebo-controlled crossover trial for children. It was a natural next step for us to extend the line of VSL#3 products with a pediatric version and we're happy to announce that it is now available to consumers in a once daily formulation," adds Ocnean.
Unlike other probiotics, VSL#3 JUNIOR is a medical food and requires refrigeration to preserve its 8 proprietary strains of 225 billion live bacteria, making it one of the few probiotics with this many strains and about 50 times more potent than the average probiotic (2) . VSL#3 JUNIOR is all-natural and comes in watermelon, a kid-pleasing flavor, making compliance less of an issue.
"There has been extensive clinical research in patients who added VSL#3 to their daily regimen, and the evidence
|Contact: Nicole Egan|
Robin Leedy & Associates, Inc.